作者：
Maria A,Karalexi [1]
;
Margarita,Baka [2]
;
Anton,Ryzhov [3]
;
Anna,Zborovskaya [4]
;
Nadya,Dimitrova [5]
;
Snezana,Zivkovic [6]
;
Sultan,Eser [7]
;
Luis,Antunes [8]
;
Mario,Sekerija [9]
;
Tina,Zagar [10]
;
Joana,Bastos [11]
;
Anna,Demetriou [12]
;
Domenic,Agius [13]
;
Margareta,Florea [14]
;
Daniela,Coza [15]
;
Sophia,Polychronopoulou [16]
;
Eftichia,Stiakaki [17]
;
Maria,Moschovi [18]
;
Emmanuel,Hatzipantelis [19]
;
Maria,Kourti [20]
;
Stelios,Graphakos [21]
;
Maria S,Pombo-de-Oliveira [22]
;
Hans Olov,Adami [23]
;
Eleni Th,Petridou [24]
作者单位：
Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, University of Athens, 75 Mikras Asias Str, Athens, 11527, Greece.
[1]
Department of Pediatric Hematology-Oncology, "Pan & Agl. Kyriakou" Children's Hospital, Thivon and Papadiamantopoulou Str, 11527, Athens, Greece.
[2]
National Cancer Registry of Ukraine, National Institute of Cancer, Lomonosova str, 33/43, Kyiv, 03022, Ukraine.
[3]
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Childhood Cancer Subregistry of Belarus, Lesnoe-2, 223040, Minsk Region, Belarus.
[4]
Bulgarian National Cancer Registry, National Oncology Hospital, 6, Plovdivsko Pole Street, Sofia, 1756, Bulgaria.
[5]
Institute of Public Health of Serbia, Dr Subotica 5, Belgrade, 11000, Serbia.
[6]
Izmir Cancer Registry, Izmir Hub, Izmir & Hacettepe University Institute of Public Health, Zubeyde Hanim Caddesi No:100, Karsiyaka, Izmir, 35067, Turkey.
[7]
North Region Cancer Registry of Portugal (RORENO), Portuguese Oncology Institute of Porto, Rua António Bernardino da Almeida, Porto, 4200-072, Portugal.
[8]
Croatian National Cancer Registry, Croatian Institute of Public Health, Rockefellerova 7, Zagreb, 10000, Croatia.
[9]
Cancer Registry of Republic of Slovenia, Institute of Oncology, Zaloška cesta 2, SI-1000, Ljubljana, Slovenia.
[10]
Central Region Cancer Registry of Portugal (ROR-Centro), Portuguese Oncology Institute of Coimbra, Av. Bissaya Barreto 98, 3000-075, Coimbra, Portugal.
[11]
Cyprus Cancer Registry-Health Monitoring Unit, Ministry of Health, 1 Prodromou Str & 17 Chilonos Str, Nicosia, 1448, Cyprus.
[12]
Malta National Cancer Registry, Department of Health Information and Research, 95, Guardamangia Hill, Guardamangia, MSD 08, Malta.
[13]
Regional Cancer Registry of Iasio, National Institute of Public Health, 14 Victor Babes Street 700465, Iasi, Romania.
[14]
Regional Cancer Registry of Cluj, Oncological Institute "Ion Chiricuta", Republicii Str no. 34-36, Cluj Napoca, 400015, Romania.
[15]
Department of Pediatric Haematology-Oncology, "Aghia Sophia" Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece.
[16]
Department of Pediatric Hematology-Oncology, University of Crete, University Hospital of Heraklion, Arsinois 23, Heraklion Crete, 71303, Greece.
[17]
Haematology-Oncology Unit, First Department of Pediatrics, Athens University Medical School, "Aghia Sophia" Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece.
[18]
2nd Department of Pediatrics, Aristotelion University of Thessaloniki, AHEPA General Hospital, Thessaloniki, Greece.
[19]
Department of Pediatric Hematology and Oncology, Hippokration Hospital, Konstantinoupoleos Str 49, Thessaloniki, 54642, Greece.
[20]
Stem Cell Transplantion Unit, Aghia Sophia Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece.
[21]
Pediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, 20230-130, Brazil.
[22]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, USA; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Kirkeveien 166, Frederik Holsts hus, Oslo, 0450, Norway.
[23]
Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, University of Athens, 75 Mikras Asias Str, Athens, 11527, Greece. Electronic address: epetrid@med.uoa.gr.
[24]
主题词
青少年(Adolescent);年龄因素(Age Factors);儿童(Child);儿童, 学龄前(Child, Preschool);欧洲(Europe);欧洲, 东部(Europe, Eastern);女(雌)性(Female);人类(Humans);婴儿(Infant);婴儿, 新生(Infant, Newborn);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);分子靶向治疗(Molecular Targeted Therapy);多元分析(Multivariate Analysis);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);预后(Prognosis);比例危险度模型(Proportional Hazards Models);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);登记(Registries);SEER规划(SEER Program);存活率(Survival Rate);美国(United States)
DOI
10.1016/j.ejca.2016.08.011
PMID
27677054
发布时间
2017-12-30
换一批
换一批
